Concomitant andexanet alfa and 4 F-PCC for Factor Xa inhibitor associated intracranial hemorrhage

Orban, JE; Ruckel, C; Harlan, S

Orban, JE (通讯作者),Lexington Med Ctr, 2720 Sunset Blvd, W Columbia, SC 29169 USA.

CLINICAL NEUROLOGY AND NEUROSURGERY, 2023; 233 ():

Abstract

Andexanet alfa is the only FDA approved drug for acute reversal of life-threatening bleeding associated with oral factor Xa inhibitor agents. The case......

Full Text Link